I wrote earlier in this thread that a new drug ought to be studied to actual rather than surrogate endpoint/s, and gave a cholesterol-lowering medication as an example. This article came to my inbox today:
http://my.webmd.com/content/article/91/101005.htm "...Vytorin's imminent approval has some experts excited because of studies showing it can lower LDL or "bad" cholesterol more effectively than a statin alone. "But others are urge caution, warning that Vytorin's manufacturers have not proven that the drug actually prevents more cardiovascular events or deaths than currently available drugs..." OK, so I _do_ like to have back-up for my opinions... <wry smile> Debbi Addicted To Documentation? Maru __________________________________ Do you Yahoo!? Yahoo! Mail - You care about security. So do we. http://promotions.yahoo.com/new_mail _______________________________________________ http://www.mccmedia.com/mailman/listinfo/brin-l
